معرفی
Andreas H. Hielscher is Professor and Chair of the Department of Biomedical Engineering at the New York University Tandon School of Engineering. He leads the recently established Department of Biomedical Engineering and directs research in his Clinical Biophotonics Laboratory (CBL). Prior to joining NYU Tandon in summer 2021, he spent 20 years at Columbia University where he chaired the Provost's Tenure Track Advisory Committee and built a distinguished career in biomedical optics research.
Dr. Hielscher received his education from the following institutions:
- Postdoctoral Fellow, Division Biosciences and Biotechnology, Los Alamos National Laboratories (1995-1998)
- Ph.D., Department of Electrical and Computer Engineering, Rice University (1991-1995)
- "Diplom" (~Master of Science), Department of Quantum Optics, University of Hannover, Germany (1989-1991)
Dr. Hielscher's research focuses on developing optical tomography as a viable biomedical imaging modality for clinical practice. His work centers on creating patient-centered approaches that address modern precision medicine through cutting-edge imaging hardware and software. His team develops technology that provides 3-dimensional distributions of physiologically relevant parameters such as oxygen saturation and total hemoglobin concentrations, including wearable devices for continuous patient monitoring. The Clinical Biophotonics Laboratory applies this technology in clinical and preclinical studies focusing on breast cancer, arthritis, peripheral artery disease (PAD), diabetic foot syndrome (DFS), and real-time brain activity monitoring.
Analysis of Dr. Hielscher's recent publications reveals a strong translational research trajectory, moving from fundamental algorithm development to clinical validation across multiple medical specialties. His work demonstrates particular innovation in developing practical, wearable, and non-contact imaging systems that can be readily implemented in clinical settings, with significant contributions to breast cancer monitoring during chemotherapy, vascular medicine (PAD and DFS), and rheumatology (arthritis and lupus).
Dr. Hielscher has received research support from multiple prestigious funding sources:
- National Heart, Lung, and Blood Institute (Grant No. NHLBI-1R01-HL115336)
- Wallace H. Coulter Foundation
- Society of Vascular Surgery
- Columbia University Fu Foundation School of Engineering and Applied Science
- New York University Tandon School of Engineering
Dr. Hielscher's laboratory includes researchers such as Nisha Maheshwari and Alessandro Marone, and maintains strong collaborations with clinicians to develop state-of-the-art biomedical optical imaging technology. The laboratory's recent work has demonstrated significant clinical impact, particularly in the 2022 study that achieved 93% accuracy in predicting wound healing outcomes for peripheral artery disease patients within one month after surgical intervention.
حوزههای پژوهشی
